Bayer AG (BAYGn.DE) Key Developments | Reuters.com
Edition:
United States

Bayer AG (BAYGn.DE)

BAYGn.DE on Xetra

87.64EUR
24 Jun 2016
Change (% chg)

€-5.53 (-5.94%)
Prev Close
€93.17
Open
€85.00
Day's High
€90.11
Day's Low
€85.00
Volume
7,953,988
Avg. Vol
3,013,250
52-wk High
€138.00
52-wk Low
€83.45

Latest Key Developments (Source: Significant Developments)

Bayer makes new takeover approach to Monsanto at same price,Monsanto rebuffs new Bayer approach,seeking higher offer-CNBC,citing DJ
Friday, 10 Jun 2016 02:11pm EDT 

: Bayer makes new takeover approach to Monsanto at same price, Monsanto rebuffs new Bayer approach, seeking higher offer - CNBC, citing DJ Further company coverage: [MON.N] (Bengaluru Newsroom) ((+1 646 223 8780;)).  Full Article

Orion and Bayer start new phase III study of prostate cancer drug
Friday, 3 Jun 2016 02:30am EDT 

Orion Oyj : Says Orion and Bayer expand clinical development program for ODM-201 and initiate a new phase III study Arasens in patients with metastatic hormone-sensitive prostate cancer . Says new the study will evaluate the safety and efficacy of the compound in combination with standard androgen deprivation therapy (ADT) and the chemotherapy docetaxel in men with newly diagnosed metastatic hormone-sensitive prostate cancer .Says new trial is expected to start the enrolment of patients towards the end of 2016.  Full Article

Bayer, Monsanto have yet to engage in meaningful dialogue - CNBC
Wednesday, 1 Jun 2016 09:52am EDT 

: Bayer, Monsanto have yet to engage in meaningful dialogue; Bayer meeting with investors in Boston & New York - CNBC citing sources (Bengaluru Newsroom) ((+1 646 223 8780;)).  Full Article

Resources needed for effective US Zika response-CDC director
Thursday, 26 May 2016 02:08pm EDT 

Bayer Ag : US CDC director Frieden says narrow window to scale up effective Zika prevention in us is closing . CDC director thanks Bayer for "substantial" donation to help fight Zika in Puerto Rico . CDC director says need to make sure we have resources necessary to deal with zika crisis . CDC director says hopes congress will do right thing for zika without taking resources from other efforts like ebola . CDC director says need to ensure we have enough money to pay back what we've borrowed and take necessary measures to fight Zika . US CDC director says no public health reason to cancel or delay Olympics .CDC director says will be at least year or two before we know if any Zika vaccine safe and effective.  Full Article

Bayer & Monsanto to engage soon in negotiations to see if they can reach a deal - CNBC, citing sources
Wednesday, 25 May 2016 09:54am EDT 

Bayer & Monsanto :To engage soon in negotiations to determine if they can reach a deal- CNBC, citing sources.  Full Article

Fitch puts Bayer AG on rating watch negative
Tuesday, 24 May 2016 01:35pm EDT 

Fitch: Fitch puts bayer ag on rating watch negative . Fitch - Has Placed Bayer Ag's (Bayer) 'A' Long term issuer default rating (IDR) on rating watch negative . Fitch on BAYER - Upon completion of transaction, will likely downgrade bayer's ratings by at least two notches .Fitch - Rating action follows Bayer's announcement that it intends to launch a formal offer to acquire US-based chemical company monsanto for $62 billion.  Full Article

Monsanto views Bayer's current proposal financially inadequate; says open to discussions
Tuesday, 24 May 2016 12:55pm EDT 

Monsanto Co : Monsanto views Bayer's current proposal as incomplete and financially inadequate; company open to discussing potential path forward that would create appropriate value for Monsanto shareowners . Monsanto board of directors has not set a timeline for further discussions . "Open to continued and constructive conversations" to assess if a transaction in "best interest of Monsanto shareowners can be achieved" ."There is no assurance that any transaction will be entered into or consummated, or on what terms".  Full Article

Moody's reviews Bayer's ratings for downgrade on Monsanto acquisition announcement
Tuesday, 24 May 2016 12:37pm EDT 

Moody's: Moody's reviews Bayer's ratings for downgrade on Monsanto acquisition announcement . Review was triggered by Bayer's announcement of a $122 per share all-cash offer to acquire Monsanto for an aggregate value of $62 billion .Cautions deal will give rise to significant execution, reputational and integration risks.  Full Article

S&P places Bayer on Watch Negative after Monsanto acquisition approach
Friday, 20 May 2016 11:20am EDT 

S&P: Germany-based life sciences group Bayer on Watch Negative following acquisition approach to Monsanto . Based on understanding of Bayer's long-term financial policy, potential approach to funding, believe rating downside likely to be limited to 2 notches .Expect business risk profile assessment of combined group would likely be at upper end of strong business risk profile currently ascribed to Bayer.  Full Article

Moody's: Bayer's bid is a credit negative for Monsanto's Bondholders
Thursday, 19 May 2016 02:01pm EDT 

: Moody's: Bayer's bid is a credit negative for Monsanto's Bondholders . Moody's - Bid by Bayer AG, unless structured as a merger, would be a negative for Monsanto's bondholders, as cost is likely to be in excess of $50 billion . Moody's - Bid by Bayer makes strategic sense for both companies as agricultural chemical and seed companies are under pressure to consolidate Source - http://bit.ly/1suTgwp Further company coverage: [MON.N] (Bengaluru Newsroom; +1 646 223 8780).  Full Article

Bayer, Dupont join ag-tech investment boom to ease grain pain

CHICAGO Dupont and Bayer AG have teamed up to invest in a new fund that will back agricultural technology startups, becoming the latest companies to pile into the multibillion-dollar industry as farm profits shrink.